Origin Asset Management’s AbbVie ABBV Stock Holding History

Origin Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-34,000	Closed	-$3.83M	–	44
2021 Q2	$3.83M	Hold	34,000	–	–	0.43%	19
2021 Q1	$3.68M	Sell	34,000 -2,100	-6%	-$225K	0.38%	20
2020 Q4	$3.87M	Hold	36,100	–	–	0.37%	19
2020 Q3	$3.16M	Sell	36,100 -5,100	-12%	-$480K	0.34%	21
2020 Q2	$4.04M	Buy	41,200 +13,200	+47%	+$1.16M	0.59%	16
2020 Q1	$2.13M	Buy	28,000 +4,000	+17%	+$341K	0.27%	41
2019 Q4	$2.13M	Buy	+24,000	New	+$1.99M	0.18%	85
2019 Q2	–	Sell	-52,200	Closed	-$4.21M	–	83
2019 Q1	$4.21M	Sell	52,200 -101,200	-66%	-$8.28M	0.35%	72
2018 Q4	$14.1M	Sell	153,400 -85,900	-36%	-$7.55M	1.29%	31
2018 Q3	$22.6M	Buy	239,300 +2,000	+0.8%	+$190K	1.47%	25
2018 Q2	$22M	Buy	237,300 +63,000	+36%	+$6.15M	1.56%	22
2018 Q1	$16.5M	Buy	174,300 +31,000	+22%	+$3.41M	1.04%	43
2017 Q4	$13.9M	Hold	143,300	–	–	0.79%	47
2017 Q3	$12.7M	Buy	+143,300	New	+$10.9M	0.78%	46

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Origin Asset Management's ABBV Position: Q3 2021 in Review

Origin Asset Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 34,000 shares — an estimated $3.83M sold.

Origin Asset Management first reported a position in ABBV in Q3 2017 and held it in 14 quarters. The position peaked at $22.6M in Q3 2018. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Origin Asset Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
Origin Asset Management sold 34,000 AbbVie shares in Q3 2021, an estimated $3.83M.
Origin Asset Management first reported a position in AbbVie in Q3 2017 and held it in 14 quarters.
Origin Asset Management's AbbVie position peaked at $22.6M in Q3 2018.
2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Origin Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.